Notable Analyst Rating Changes 06/25: (MRVL) (LVS) (LRCX) Upgraded; (NFLX) (PAAS) (DMD) Downgraded
Get Alerts MRVL Hot Sheet
Join SI Premium – FREE
UPGRADES
Brean Capital raises Marvell (Nasdaq: MRVL) from Hold to Buy with a price target of $13.
Craig-Hallum upgrades Las Vegas Sands (NYSE: LVS) from Neutral to Buy with a price target of $59. Click Here for more color.
CLSA moves Lam Research (Nasdaq: LRCX) from Underperform to Outperform, adjusting its price target from $50 up to $55.
Hilliard Lyons boosts Zoetis Inc. (NYSE: ZTS) from Neutral to Buy.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Bernstein downgrades Netflix (Nasdaq: NFLX) from Market Perform to Underperform, moving its price target from $125 up to $180.
Demand Media (NYSE: DMD) downgraded by two today:
Cowen cuts Pan Am Silver (Nasdaq: PAAS) from Outperform to Market Perform.
William Blair trims Titan Machinery (Nasdaq: TITN) from Outperform to Market Perform.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Epizyme (Nasdaq: EPZM) started by several firms Tuesday:
First Analysis initiates coverage on Intuitive Surgical (Nasdaq: ISRG) with an Equal Weight.
William Blair assumes Francesca's Holdings (Nasdaq: FRAN) at Outperform.
Piper Jaffray starts Mast Therapeutics (NYSE: MSTX) with an Overweight and $1 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Brean Capital raises Marvell (Nasdaq: MRVL) from Hold to Buy with a price target of $13.
Craig-Hallum upgrades Las Vegas Sands (NYSE: LVS) from Neutral to Buy with a price target of $59. Click Here for more color.
CLSA moves Lam Research (Nasdaq: LRCX) from Underperform to Outperform, adjusting its price target from $50 up to $55.
Hilliard Lyons boosts Zoetis Inc. (NYSE: ZTS) from Neutral to Buy.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Bernstein downgrades Netflix (Nasdaq: NFLX) from Market Perform to Underperform, moving its price target from $125 up to $180.
Demand Media (NYSE: DMD) downgraded by two today:
- JMP Securities from Market Outperform to Market Perform; and
- Stifel Nicolaus from Buy to Hold.
Cowen cuts Pan Am Silver (Nasdaq: PAAS) from Outperform to Market Perform.
William Blair trims Titan Machinery (Nasdaq: TITN) from Outperform to Market Perform.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Epizyme (Nasdaq: EPZM) started by several firms Tuesday:
- Citi at Buy and $32 price target;
- Cowen with an Outperform;
- JMP Securities at Market Outperform;
- Leerink Swann at Outperform and price target of $34.
First Analysis initiates coverage on Intuitive Surgical (Nasdaq: ISRG) with an Equal Weight.
William Blair assumes Francesca's Holdings (Nasdaq: FRAN) at Outperform.
Piper Jaffray starts Mast Therapeutics (NYSE: MSTX) with an Overweight and $1 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: GameStop falls; Merck, Robinhood and Moderna rise
- Midday movers: Mobileye, Chipotle rise; Signet, BioNTech fall
- Nkarta (NKTX) Prices $240M Share and Warrant Offering at $10/sh
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Piper Jaffray, Stifel, William Blair, Citi, JMP Securities, First Analysis, Hilliard Lyons, Notable Analyst Rating Changes, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!